Abstracts - faqs.org

Abstracts

Mass communications

Search abstracts:
Abstracts » Mass communications

Gladiator's win boosts More 4

Article Abstract:

The screening of "Gladiator" on More 4 during the bank holiday took a 3% share a big boost compared to the digital television channel's average weekly share of under 1%. More 4's shows include "Relocation, Relocation", "Come Dine with Me" and the highly rating "The World's Biggest Penis". The audience share ratings of other television programs on More 4 are also discussed.

Author: Reevell, Phillip
Publisher: EMAP Maclaren Ltd.
Publication Name: Broadcast
Subject: Mass communications
ISSN: 0040-2788
Year: 2007
Services information, Services, Digital television

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Week ending: 27 November

Article Abstract:

The weekly rating of television programs for the week ended on November 27, 2005, is presented. Other statistics relevant to rating of channels are also presented.

Publisher: EMAP Maclaren Ltd.
Publication Name: Broadcast
Subject: Mass communications
ISSN: 0040-2788
Year: 2005
Labor Distribution by Employer, Statistics, Illustration, Television audience ratings, Rankings

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United Kingdom, Television programs, Market share, Television stations, Company market share
Similar abstracts:
  • Abstracts: Broadcast/Barb top 50. Broadcast/Barb top 50: week ending 5 November 2000
  • Abstracts: Ratings: week ending 29 July. The best possible taste. All I want for Christmas
  • Abstracts: Who won the 24-hour news war? Ratings: week ending 6 May
  • Abstracts: Ratings. British hopes boost tennis ratings
  • Abstracts: Sky 1 receives GBP1 million revamp. World and BSkyB strike movie deal
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.